IPOs

Fresh off its IPO, Sagimet adds two former Cognoa execs to corner office
Medical Marketing and Media
Sun, 07/23/23 - 12:42 pm
Sagimet Biosciences
IPOs
compliance
Cell therapy startup Turnstone adds to biotech IPO flurry with $80M raise
BioPharma Dive
Fri, 07/21/23 - 10:10 am
IPOs
Turnstone Biologics
cell therapy
Apogee, Sagimet overshoot IPO expectation as both biotechs land on Nasdaq
Fierce Biotech
Tue, 07/18/23 - 11:34 am
NASDAQ
IPOs
Apogee Therapeutics
Sagimet Biosciences
7 Life Science IPOs in 2023
BioSpace
Wed, 07/12/23 - 09:48 am
IPOs
Intensity Therapeutics
Acelyrin
CytoMed Therapeutics
Mineralys Therapeutics
Structure Therapeutics
Genelux
Cadrenal Therapeutics
Biophama's flotation haul creeps higher
EP Vantage
Thu, 07/6/23 - 10:09 am
IPOs
biotech
Acelyrin
Apogee Therapeutics
Azitra
CytoMed Therapeutics
Intensity Therapeutics
Mineralys Therapeutics
Paragon Therapeutics
Sagimet Biosciences
Structure Therapeutics
Turnstone Biologics
Intensity Therapeutics Prices Upsized 3.9M Share IPO at $5/sh
Investing.com
Fri, 06/30/23 - 11:47 am
Intensity Therapeutics
oncology
cancer
IPOs
Apogee Files for IPO with Promising Preclinical Immuno Asset
BioSpace
Sun, 06/25/23 - 09:37 pm
Paragon Therapeutics
IPOs
asthma
atopic dermatitis
Turnstone Biologics Files for $86M IPO Amid Financial Difficulties
BioSpace
Wed, 06/14/23 - 10:09 am
Turnstone Biologics
IPOs
NASDAQ
Biotech IPOs in 2023: Shaping the Future of Innovation
Xtalks
Wed, 05/31/23 - 06:52 pm
biotech
IPOs
So you think you can go public? Few biotechs dance with Wall Street
Fierce Biotech
Mon, 05/8/23 - 11:52 pm
biotech
IPOs
Structure Therapeutics
Mineralys Therapeutics
Coya Therapeutics
Acelyrin makes a splash with IPO, biopharma expects to raise $540M
Medical Marketing and Media
Sun, 05/7/23 - 10:16 pm
Acelyrin
IPOs
Acelyrin follows Kenvue with largest IPO for a biotech startup since 2021
BioPharma Dive
Fri, 05/5/23 - 12:08 pm
Acelyrin
IPOs
Kenvue
J&J sets top price for consumer health unit Kenvue’s IPO
Pharmaphorum
Thu, 05/4/23 - 09:57 am
JNJ
spinoff
Kenvue
IPOs
consumer health
Johnson & Johnson consumer health unit valued at $40 billion ahead of IPO, report says
CNBC
Tue, 04/25/23 - 10:44 am
JNJ
consumer health
IPOs
Kenvue
spinoffs
IPO Market Shows Signs of Life as Acelyrin Begins Nasdaq Bid
BioSpace
Sun, 04/16/23 - 11:10 pm
Acelyrin
IPOs
immunology
After a record run, fewer biotechs are going public. Here’s how they’re performing.
BioPharma Dive
Fri, 04/14/23 - 10:21 am
biotech
IPOs
Floating biotechs prompt tiny sparks of hope
EP Vantage
Mon, 04/10/23 - 11:16 am
IPOs
biotech
Mineralys Therapeutics
Structure Therapeutics
Genelux
Cadrenal Therapeutics
BioXcel takes surprising path with IPO of oncology spinout OnkosXcel
Fierce Biotech
Wed, 03/15/23 - 09:37 pm
BioXcel
IPOs
oncology
OnkosXcel
IPOs vs SPACs
EP Vantage
Thu, 03/9/23 - 09:47 am
IPOs
SPAC
Belite Bio
Cerevel Therapeutics
NewAmsterdam Pharma
Nuvectis Pharma
Oculis
Roivant Sciences
A small Connecticut biotech throws hat into IPO ring
Endpoints
Tue, 02/21/23 - 04:28 pm
Azitra
IPOs
skin diseases
dermatology

Pages